Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Bullboard Posts
Post by mercedesmanon Oct 10, 2019 10:09am
201 Views
Post# 30216684

If only there was a simple blood test...

If only there was a simple blood test...
https://www.ubyssey.ca/science/sepsis-early-blood-testing/

Their findings showed that taking blood cultures after administering antibiotics could decrease their sensitivity by nearly 50 per cent, affecting medical professionals’ ability to identify an infecting pathogen.

“… there’s many reasons why that loss of information is unacceptable,” said Dr. David Sweet, a study author, clinical associate professor in the faculty of medicine at UBC and clinical lead for sepsis with BC Patient Safety & Quality Council (BCPSQC).

As sepsis can be triggered by a broad range of infections, blood cultures can play an important role during the treatment process by identifying the specific organism responsible for the infection. This allows clinicians to administer a selective antibiotic, such as penicillin, as opposed to aggressive broad-spectrum antibiotics, which can pose health consequences to patients when delivered long-term.

Bullboard Posts